18 of 23
BACKNEXT
18. Gilead Sciences
18. Gilead Sciences
2010 Fortune 500 rank: 324
2009 profit growth: 31.1%
2009 revenue growth: 31.4%

CEO since 1996: John C Martin

Under CEO John Martin's direction, Gilead developed the first one-pill, once-a-day AIDS treatment that eliminates many of the side effects of earlier drug cocktails.

Gilead already has dominant position in AIDS treatment, so stealing market share won't lead to big growth.

Instead, Martin hopes that new guidelines recommending earlier treatment will boost sales. In 2009, they were up 31%, to $7 billion, and profits were up 31% to $2.6 billion.

NEXT: 19. AECOM Technology

Email | Print | Share
 
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
Last updated April 28 2010: 12:37 PM ET
Top 50 Wal-Mart knocks Exxon Mobil out of the No. 1 slot to rule the Fortune 500 again. Which other companies made the top 50 this year? More
They're hiring! These Fortune 100 employers have at least 200 openings each, totaling more than 60,000 jobs. What are they looking for in a new hire? More
The biggest losers Companies from Fannie Mae to RiteAid, and Citigroup to Sprint lost billions of dollars last year. Who lost the most? More